Kernel-Based Partial Least Squares: Application to Fingerprint-Based QSAR with Model Visualization
暂无分享,去创建一个
[1] Chang Park,et al. Structure-based design, synthesis, and biological evaluation of potent and selective macrocyclic checkpoint kinase 1 inhibitors. , 2007, Journal of medicinal chemistry.
[2] R. Knabb,et al. Synthesis and SAR of benzamidine factor Xa inhibitors containing a vicinally-substituted heterocyclic core. , 2001, Bioorganic & medicinal chemistry letters.
[3] Scott A. Erickson,et al. Discovery and optimization of anthranilic acid sulfonamides as inhibitors of methionine aminopeptidase-2: a structural basis for the reduction of albumin binding. , 2006, Journal of medicinal chemistry.
[4] Yvonne C. Martin,et al. The Information Content of 2D and 3D Structural Descriptors Relevant to Ligand-Receptor Binding , 1997, J. Chem. Inf. Comput. Sci..
[5] Gergana Dimitrova,et al. A Stepwise Approach for Defining the Applicability Domain of SAR and QSAR Models , 2005, J. Chem. Inf. Model..
[6] Darren R. Flower,et al. On the Properties of Bit String-Based Measures of Chemical Similarity , 1998, J. Chem. Inf. Comput. Sci..
[7] Steven L. Dixon,et al. Investigation of classification methods for the prediction of activity in diverse chemical libraries , 1999, J. Comput. Aided Mol. Des..
[8] Anna Vulpetti,et al. Benzodipyrazoles: a new class of potent CDK2 inhibitors. , 2005, Bioorganic & medicinal chemistry letters.
[9] S. Wold,et al. The Collinearity Problem in Linear Regression. The Partial Least Squares (PLS) Approach to Generalized Inverses , 1984 .
[10] Robert Steffan,et al. Indazole-based liver X receptor (LXR) modulators with maintained atherosclerotic lesion reduction activity but diminished stimulation of hepatic triglyceride synthesis. , 2008, Journal of medicinal chemistry.
[11] Woody Sherman,et al. Hole filling and library optimization: application to commercially available fragment libraries. , 2012, Bioorganic & medicinal chemistry.
[12] Woody Sherman,et al. Analysis and comparison of 2D fingerprints: insights into database screening performance using eight fingerprint methods , 2010, J. Cheminformatics.
[13] Roman Rosipal,et al. Kernel Partial Least Squares Regression in Reproducing Kernel Hilbert Space , 2002, J. Mach. Learn. Res..
[14] Corinna Cortes,et al. Support-Vector Networks , 1995, Machine Learning.
[15] Robert P. Sheridan,et al. Similarity to Molecules in the Training Set Is a Good Discriminator for Prediction Accuracy in QSAR , 2004, J. Chem. Inf. Model..
[16] Lawrence C Kuo,et al. Unexpected enhancement of thrombin inhibitor potency with o-aminoalkylbenzylamides in the P1 position. , 2003, Bioorganic & medicinal chemistry letters.
[17] Frank R. Burden,et al. Holographic QSAR of benzodiazepines , 1998 .
[18] Yvonne C. Martin,et al. Use of Structure-Activity Data To Compare Structure-Based Clustering Methods and Descriptors for Use in Compound Selection , 1996, J. Chem. Inf. Comput. Sci..
[19] P. A. Harris,et al. Oxindole-based inhibitors of cyclin-dependent kinase 2 (CDK2): design, synthesis, enzymatic activities, and X-ray crystallographic analysis. , 2001, Journal of medicinal chemistry.
[20] R. Cramer,et al. Comparative molecular field analysis (CoMFA). 1. Effect of shape on binding of steroids to carrier proteins. , 1988, Journal of the American Chemical Society.
[21] Mike Wood,et al. 4,5-diarylisoxazole Hsp90 chaperone inhibitors: potential therapeutic agents for the treatment of cancer. , 2007, Journal of medicinal chemistry.
[22] D L Cheney,et al. Design and structure-activity relationships of potent and selective inhibitors of blood coagulation factor Xa. , 1999, Journal of medicinal chemistry.
[23] Igor V. Tetko,et al. Critical Assessment of QSAR Models of Environmental Toxicity against Tetrahymena pyriformis: Focusing on Applicability Domain and Overfitting by Variable Selection , 2008, J. Chem. Inf. Model..
[24] David E. Shaw,et al. PHASE: a new engine for pharmacophore perception, 3D QSAR model development, and 3D database screening: 1. Methodology and preliminary results , 2006, J. Comput. Aided Mol. Des..
[25] Gilles Klopman,et al. Antifungal triazole alcohols: A comparative analysis of structure-activity, structure-teratogenicity and structure-therapeutic index relationships using the Multiple Computer-Automated Structure Evaluation (Multi-CASE) methodology , 1993, J. Comput. Aided Mol. Des..
[26] Keizo Yamashita,et al. Highly potent inhibitors of methionine aminopeptidase-2 based on a 1,2,4-triazole pharmacophore. , 2007, Journal of medicinal chemistry.
[27] Woody Sherman,et al. Large-Scale Systematic Analysis of 2D Fingerprint Methods and Parameters to Improve Virtual Screening Enrichments , 2010, J. Chem. Inf. Model..
[28] D. Hand,et al. Idiot's Bayes—Not So Stupid After All? , 2001 .
[29] Anton J. Hopfinger,et al. Four-Dimensional Quantitative Structure-Activity Relationship Analysis of a Series of Interphenylene 7-Oxabicycloheptane Oxazole Thromboxane A2 Receptor Antagonists , 1998, J. Chem. Inf. Comput. Sci..
[30] G. Klebe,et al. Molecular similarity indices in a comparative analysis (CoMSIA) of drug molecules to correlate and predict their biological activity. , 1994, Journal of medicinal chemistry.